Annual report
3154.TEDINET S100Z02T
Period2022-07-01 → 2023-06-30
Filed2026-09-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100RXO4. Amended by S100Z0AU (2026-09-03).
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥239.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥226.6bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥213.3bn | 2020-07-01 → 2021-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥210.4bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥197.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2022-07-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.5bn | 2022-07-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥951m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥70m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.5bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥97.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥84.5bn | at 2021-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥70.0bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥62.0bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥78.9bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.6bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30v | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2020-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.7bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.3bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.3bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.2bn | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥3.9bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥863m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥138m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥863m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.2bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥788m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥68.32 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.66 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥68.09 | 2022-07-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.6 | 2019-07-01 → 2020-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥847.1 | at 2023-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥789.43 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥727.12 | at 2021-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥636.71 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥582.16 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 19.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2022-07-01 → 2023-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.9% | 2020-07-01 → 2021-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.6% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,288 | at 2023-06-30 | Cons. | Number of employees |
| Employees | 2,182 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 2,002 | at 2021-06-30v | Cons. | Number of employees |
| Employees | 1,926 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 1,680 | at 2019-06-30d | Cons. | Number of employees |
| Revenue | ¥3.0bn | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥2.7bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2020-07-01 → 2021-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥743m | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | ¥732m | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥968m | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥998m | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥703m | 2020-07-01 → 2021-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥486m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥573m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥957m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | ¥1.0bn | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥932m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥663m | 2020-07-01 → 2021-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥853m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥614m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥22.8bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥23.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥21.5bn | at 2021-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.5bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.1bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥13.5bn | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥15.2bn | at 2022-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥9.3bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-06-30v | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.8bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥298m | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥372m | at 2022-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥46.27 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.56 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.43 | 2020-07-01 → 2021-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.16 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.16 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.12 | 2022-07-01 → 2023-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥42.48 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.22 | 2020-07-01 → 2021-06-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥39.12 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥22 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2020-07-01 → 2021-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥425.81 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥394.52 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥372.32 | at 2021-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.09 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥310.69 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.9% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.8% | at 2021-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.5% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.4% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.1% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-07-01 → 2021-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -10.0% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,925,104 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,925,104 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2021-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,789,724 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 90 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 71 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 74 | at 2021-06-30v | Standalone | Number of employees |
| Employees | 73 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 66 | at 2019-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥418m |
| Reconciling Itemsreconciling | depreciation | 2022-07-01 → 2023-06-30 | ¥703m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥240,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥240,000 |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | ¥40.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-06-30 | −¥7.8bn |
| Medical Equipment Salesreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥506m |
| Medical Equipment Salesreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥312m |
| Medical Equipment Salesreportable segment | employees | at 2023-06-30 | 1760 pure |
| Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥233.6bn |
| Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥233.6bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥240,000 |
| Medical Equipment Salesreportable segment | segment assets | at 2023-06-30 | ¥55.8bn |
| Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥9.3bn |
| Nursing Welfarereportable segment | capex | 2022-07-01 → 2023-06-30 | ¥479m |
| Nursing Welfarereportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥463m |
| Nursing Welfarereportable segment | employees | at 2023-06-30 | 177 pure |
| Nursing Welfarereportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥5.5bn |
| Nursing Welfarereportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥5.5bn |
| Nursing Welfarereportable segment | segment assets | at 2023-06-30 | ¥1.4bn |
| Nursing Welfarereportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥405m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-07-01 → 2023-06-30 | ¥985m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-07-01 → 2023-06-30 | ¥774m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-06-30 | ¥239.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-06-30 | ¥239.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥240,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-06-30 | ¥57.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-06-30 | ¥9.7bn |
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥4.2bn |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥428m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥39.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥7.5bn |
| Medical Equipment Salesreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥507m |
| Medical Equipment Salesreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥234m |
| Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥221.3bn |
| Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥221.3bn |
| Medical Equipment Salesreportable segment | segment assets | at 2022-06-30 | ¥52.1bn |
| Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥9.3bn |
| Nursing Welfarereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥323m |
| Nursing Welfarereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥310m |
| Nursing Welfarereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Nursing Welfarereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Nursing Welfarereportable segment | segment assets | at 2022-06-30 | ¥1.1bn |
| Nursing Welfarereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥830m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥544m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥226.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥226.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥53.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥9.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,538
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in lease investment assets ope cf | CurrentYearDuration | 47496000 | JPY |
| Decrease increase in other current assets ope cf | Prior1YearDuration | -863847000 | JPY |
| Decrease increase in other current assets ope cf | CurrentYearDuration | 518840000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | -805968000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 1481875000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | -1061000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | -108328000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YearDuration | -396716000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYearDuration | 794748000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1YearDuration | 390266000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYearDuration | -264285000 | JPY |
| Other net ope cf | Prior1YearDuration | -8876000 | JPY |
| Other net ope cf | CurrentYearDuration | -1367000 | JPY |
| Subtotal ope cf | Prior1YearDuration | -2624536000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 3874773000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 48676000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 106857000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -69561000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -85179000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -1379724000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -2867426000 | JPY |
| Income taxes refund ope cf | Prior1YearDuration | 126142000 | JPY |
| Income taxes refund ope cf | CurrentYearDuration | 195461000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | -3899003000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 1224486000 | JPY |
| Payments into time deposits inv cf | Prior1YearDuration | -60194000 | JPY |
| Payments into time deposits inv cf | CurrentYearDuration | -42986000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YearDuration | 60194000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYearDuration | 74194000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration | -4270208000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -553245000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 7706000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 45918000 | JPY |
| Payments for retirement of property plant and equipment inv cf | Prior1YearDuration | -328000 | JPY |
| Payments for retirement of property plant and equipment inv cf | CurrentYearDuration | -431000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -318517000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -370156000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -10837000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -11422000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 1571000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 216423000 | JPY |
| Collection of loans receivable inv cf | Prior1YearDuration | 22793000 | JPY |
| Collection of loans receivable inv cf | CurrentYearDuration | 21147000 | JPY |
| Purchase of long term prepaid expenses inv cf | Prior1YearDuration | -390726000 | JPY |
| Purchase of long term prepaid expenses inv cf | CurrentYearDuration | -471223000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YearDuration | -194419000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYearDuration | -86240000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YearDuration | 196457000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYearDuration | 153477000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | 170226000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |